Aclarion, Inc. (NASDAQ: ACONW) Stock Competitors & Peer Comparison
See ACONW's competitors and their performance on the NASDAQ and across the wider stock market.
Peer Comparison Table: Medical - Healthcare Information Services Industry
Detailed financial metrics including price, market cap, P/E ratio, and more for ACONW and its NASDAQ peers.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| ACONW | $0.02 | +4.76% | 11.7K | N/A | -$10.62 | N/A |
| VEEV | $195.38 | -1.01% | 31.7B | 23.46 | $8.33 | N/A |
| GEHC | $63.07 | -4.00% | 28.7B | 13.83 | $4.56 | +0.22% |
| GEHCV | $56.00 | -4.08% | 25.5B | N/A | N/A | N/A |
| BTSG | $70.69 | +3.71% | 13.9B | 57.01 | $1.24 | N/A |
| BTSGU | $231.53 | +1.23% | 13.5B | 209.36 | $1.11 | N/A |
| TEM | $52.47 | -2.09% | 9.2B | -104.94 | -$0.50 | N/A |
| SGFY | $30.49 | +0.07% | 8.9B | 70.91 | $0.43 | N/A |
| HQY | $97.67 | +2.73% | 8.3B | 23.06 | $4.28 | N/A |
| HNGE | $87.09 | +1.29% | 6.7B | 44.66 | $1.95 | N/A |
Stock Comparison
Veeva Systems Inc. (NYSE: VEEV)
ACONW vs VEEV Comparison July 2026
Aclarion, Inc. (NASDAQ: ACONW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACONW stands at 11.7K. In comparison, VEEV has a market cap of 31.7B. Regarding current trading prices, ACONW is priced at $0.02 on the NASDAQ, while VEEV trades at $195.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACONW currently has a P/E ratio of N/A, whereas VEEV's P/E ratio is 23.46. In terms of profitability, ACONW's ROE is -0.54%, compared to VEEV's ROE of +0.13%. Regarding short-term risk, ACONW is less volatile compared to VEEV. This indicates lower risk in terms of short-term price fluctuations for ACONW.Check VEEV's competition here
GE HealthCare Technologies Inc. (NASDAQ: GEHC)
ACONW vs GEHC Comparison July 2026
Aclarion, Inc. (NASDAQ: ACONW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACONW stands at 11.7K. In comparison, GEHC has a market cap of 28.7B. Regarding current trading prices, ACONW is priced at $0.02 on the NASDAQ, while GEHC trades at $63.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACONW currently has a P/E ratio of N/A, whereas GEHC's P/E ratio is 13.83. In terms of profitability, ACONW's ROE is -0.54%, compared to GEHC's ROE of +0.15%. Regarding short-term risk, ACONW is less volatile compared to GEHC. This indicates lower risk in terms of short-term price fluctuations for ACONW.Check GEHC's competition here
GE HealthCare Technologies Inc. (NASDAQ: GEHCV)
ACONW vs GEHCV Comparison July 2026
Aclarion, Inc. (NASDAQ: ACONW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACONW stands at 11.7K. In comparison, GEHCV has a market cap of 25.5B. Regarding current trading prices, ACONW is priced at $0.02 on the NASDAQ, while GEHCV trades at $56.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACONW currently has a P/E ratio of N/A, whereas GEHCV's P/E ratio is N/A. In terms of profitability, ACONW's ROE is -0.54%, compared to GEHCV's ROE of +0.19%. Regarding short-term risk, ACONW is less volatile compared to GEHCV. This indicates lower risk in terms of short-term price fluctuations for ACONW.Check GEHCV's competition here
BrightSpring Health Services, Inc. Common Stock (NASDAQ: BTSG)
ACONW vs BTSG Comparison July 2026
Aclarion, Inc. (NASDAQ: ACONW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACONW stands at 11.7K. In comparison, BTSG has a market cap of 13.9B. Regarding current trading prices, ACONW is priced at $0.02 on the NASDAQ, while BTSG trades at $70.69.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACONW currently has a P/E ratio of N/A, whereas BTSG's P/E ratio is 57.01. In terms of profitability, ACONW's ROE is -0.54%, compared to BTSG's ROE of +0.17%. Regarding short-term risk, ACONW is less volatile compared to BTSG. This indicates lower risk in terms of short-term price fluctuations for ACONW.Check BTSG's competition here
BrightSpring Health Services, Inc. Tangible Equity Unit (NASDAQ: BTSGU)
ACONW vs BTSGU Comparison July 2026
Aclarion, Inc. (NASDAQ: ACONW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACONW stands at 11.7K. In comparison, BTSGU has a market cap of 13.5B. Regarding current trading prices, ACONW is priced at $0.02 on the NASDAQ, while BTSGU trades at $231.53.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACONW currently has a P/E ratio of N/A, whereas BTSGU's P/E ratio is 209.36. In terms of profitability, ACONW's ROE is -0.54%, compared to BTSGU's ROE of +0.17%. Regarding short-term risk, ACONW is less volatile compared to BTSGU. This indicates lower risk in terms of short-term price fluctuations for ACONW.Check BTSGU's competition here
Tempus AI, Inc. (NASDAQ: TEM)
ACONW vs TEM Comparison July 2026
Aclarion, Inc. (NASDAQ: ACONW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACONW stands at 11.7K. In comparison, TEM has a market cap of 9.2B. Regarding current trading prices, ACONW is priced at $0.02 on the NASDAQ, while TEM trades at $52.47.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACONW currently has a P/E ratio of N/A, whereas TEM's P/E ratio is -104.94. In terms of profitability, ACONW's ROE is -0.54%, compared to TEM's ROE of -0.70%. Regarding short-term risk, ACONW is less volatile compared to TEM. This indicates lower risk in terms of short-term price fluctuations for ACONW.Check TEM's competition here
Signify Health, Inc. (NYSE: SGFY)
ACONW vs SGFY Comparison July 2026
Aclarion, Inc. (NASDAQ: ACONW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACONW stands at 11.7K. In comparison, SGFY has a market cap of 8.9B. Regarding current trading prices, ACONW is priced at $0.02 on the NASDAQ, while SGFY trades at $30.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACONW currently has a P/E ratio of N/A, whereas SGFY's P/E ratio is 70.91. In terms of profitability, ACONW's ROE is -0.54%, compared to SGFY's ROE of -0.15%. Regarding short-term risk, ACONW is less volatile compared to SGFY. This indicates lower risk in terms of short-term price fluctuations for ACONW.Check SGFY's competition here
HealthEquity, Inc. (NASDAQ: HQY)
ACONW vs HQY Comparison July 2026
Aclarion, Inc. (NASDAQ: ACONW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACONW stands at 11.7K. In comparison, HQY has a market cap of 8.3B. Regarding current trading prices, ACONW is priced at $0.02 on the NASDAQ, while HQY trades at $97.67.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACONW currently has a P/E ratio of N/A, whereas HQY's P/E ratio is 23.06. In terms of profitability, ACONW's ROE is -0.54%, compared to HQY's ROE of +0.11%. Regarding short-term risk, ACONW is less volatile compared to HQY. This indicates lower risk in terms of short-term price fluctuations for ACONW.Check HQY's competition here
Hinge Health, Inc. (NYSE: HNGE)
ACONW vs HNGE Comparison July 2026
Aclarion, Inc. (NASDAQ: ACONW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACONW stands at 11.7K. In comparison, HNGE has a market cap of 6.7B. Regarding current trading prices, ACONW is priced at $0.02 on the NASDAQ, while HNGE trades at $87.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACONW currently has a P/E ratio of N/A, whereas HNGE's P/E ratio is 44.66. In terms of profitability, ACONW's ROE is -0.54%, compared to HNGE's ROE of -1.39%. Regarding short-term risk, ACONW is less volatile compared to HNGE. This indicates lower risk in terms of short-term price fluctuations for ACONW.Check HNGE's competition here
R1 RCM Inc. (NASDAQ: RCM)
ACONW vs RCM Comparison July 2026
Aclarion, Inc. (NASDAQ: ACONW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACONW stands at 11.7K. In comparison, RCM has a market cap of 6B. Regarding current trading prices, ACONW is priced at $0.02 on the NASDAQ, while RCM trades at $14.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACONW currently has a P/E ratio of N/A, whereas RCM's P/E ratio is -102.21. In terms of profitability, ACONW's ROE is -0.54%, compared to RCM's ROE of +0.00%. Regarding short-term risk, ACONW is similarly volatile compared to RCM. This indicates similar risk in terms of short-term price fluctuations for ACONW.Check RCM's competition here
10x Genomics, Inc. (NASDAQ: TXG)
ACONW vs TXG Comparison July 2026
Aclarion, Inc. (NASDAQ: ACONW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACONW stands at 11.7K. In comparison, TXG has a market cap of 5.6B. Regarding current trading prices, ACONW is priced at $0.02 on the NASDAQ, while TXG trades at $43.74.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACONW currently has a P/E ratio of N/A, whereas TXG's P/E ratio is -257.29. In terms of profitability, ACONW's ROE is -0.54%, compared to TXG's ROE of -0.03%. Regarding short-term risk, ACONW is less volatile compared to TXG. This indicates lower risk in terms of short-term price fluctuations for ACONW.Check TXG's competition here
Doximity, Inc. (NYSE: DOCS)
ACONW vs DOCS Comparison July 2026
Aclarion, Inc. (NASDAQ: ACONW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACONW stands at 11.7K. In comparison, DOCS has a market cap of 4B. Regarding current trading prices, ACONW is priced at $0.02 on the NASDAQ, while DOCS trades at $21.52.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACONW currently has a P/E ratio of N/A, whereas DOCS's P/E ratio is 14.07. In terms of profitability, ACONW's ROE is -0.54%, compared to DOCS's ROE of +0.19%. Regarding short-term risk, ACONW is less volatile compared to DOCS. This indicates lower risk in terms of short-term price fluctuations for ACONW.Check DOCS's competition here
1Life Healthcare, Inc. (NASDAQ: ONEM)
ACONW vs ONEM Comparison July 2026
Aclarion, Inc. (NASDAQ: ACONW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACONW stands at 11.7K. In comparison, ONEM has a market cap of 3.4B. Regarding current trading prices, ACONW is priced at $0.02 on the NASDAQ, while ONEM trades at $16.47.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACONW currently has a P/E ratio of N/A, whereas ONEM's P/E ratio is -7.77. In terms of profitability, ACONW's ROE is -0.54%, compared to ONEM's ROE of -0.24%. Regarding short-term risk, ACONW is less volatile compared to ONEM. This indicates lower risk in terms of short-term price fluctuations for ACONW.Check ONEM's competition here
Privia Health Group, Inc. (NASDAQ: PRVA)
ACONW vs PRVA Comparison July 2026
Aclarion, Inc. (NASDAQ: ACONW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACONW stands at 11.7K. In comparison, PRVA has a market cap of 3.4B. Regarding current trading prices, ACONW is priced at $0.02 on the NASDAQ, while PRVA trades at $26.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACONW currently has a P/E ratio of N/A, whereas PRVA's P/E ratio is 168.13. In terms of profitability, ACONW's ROE is -0.54%, compared to PRVA's ROE of +0.03%. Regarding short-term risk, ACONW is less volatile compared to PRVA. This indicates lower risk in terms of short-term price fluctuations for ACONW.Check PRVA's competition here
Progyny, Inc. (NASDAQ: PGNY)
ACONW vs PGNY Comparison July 2026
Aclarion, Inc. (NASDAQ: ACONW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACONW stands at 11.7K. In comparison, PGNY has a market cap of 2.5B. Regarding current trading prices, ACONW is priced at $0.02 on the NASDAQ, while PGNY trades at $31.93.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACONW currently has a P/E ratio of N/A, whereas PGNY's P/E ratio is 23.31. In terms of profitability, ACONW's ROE is -0.54%, compared to PGNY's ROE of +0.13%. Regarding short-term risk, ACONW is less volatile compared to PGNY. This indicates lower risk in terms of short-term price fluctuations for ACONW.Check PGNY's competition here
Heartflow, Inc. Common Stock (NASDAQ: HTFL)
ACONW vs HTFL Comparison July 2026
Aclarion, Inc. (NASDAQ: ACONW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACONW stands at 11.7K. In comparison, HTFL has a market cap of 2.2B. Regarding current trading prices, ACONW is priced at $0.02 on the NASDAQ, while HTFL trades at $24.88.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACONW currently has a P/E ratio of N/A, whereas HTFL's P/E ratio is -12.92. In terms of profitability, ACONW's ROE is -0.54%, compared to HTFL's ROE of +8.30%. Regarding short-term risk, ACONW is less volatile compared to HTFL. This indicates lower risk in terms of short-term price fluctuations for ACONW.Check HTFL's competition here
GeneDx Holdings Corp. (NASDAQ: WGS)
ACONW vs WGS Comparison July 2026
Aclarion, Inc. (NASDAQ: ACONW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACONW stands at 11.7K. In comparison, WGS has a market cap of 1.9B. Regarding current trading prices, ACONW is priced at $0.02 on the NASDAQ, while WGS trades at $63.48.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACONW currently has a P/E ratio of N/A, whereas WGS's P/E ratio is 74.68. In terms of profitability, ACONW's ROE is -0.54%, compared to WGS's ROE of -0.28%. Regarding short-term risk, ACONW is less volatile compared to WGS. This indicates lower risk in terms of short-term price fluctuations for ACONW.Check WGS's competition here
Teladoc Health, Inc. (NYSE: TDOC)
ACONW vs TDOC Comparison July 2026
Aclarion, Inc. (NASDAQ: ACONW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACONW stands at 11.7K. In comparison, TDOC has a market cap of 1.7B. Regarding current trading prices, ACONW is priced at $0.02 on the NASDAQ, while TDOC trades at $9.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACONW currently has a P/E ratio of N/A, whereas TDOC's P/E ratio is -10.47. In terms of profitability, ACONW's ROE is -0.54%, compared to TDOC's ROE of -0.12%. Regarding short-term risk, ACONW is less volatile compared to TDOC. This indicates lower risk in terms of short-term price fluctuations for ACONW.Check TDOC's competition here
NextGen Healthcare, Inc. (NASDAQ: NXGN)
ACONW vs NXGN Comparison July 2026
Aclarion, Inc. (NASDAQ: ACONW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACONW stands at 11.7K. In comparison, NXGN has a market cap of 1.6B. Regarding current trading prices, ACONW is priced at $0.02 on the NASDAQ, while NXGN trades at $23.94.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACONW currently has a P/E ratio of N/A, whereas NXGN's P/E ratio is -266.00. In terms of profitability, ACONW's ROE is -0.54%, compared to NXGN's ROE of -0.01%. Regarding short-term risk, ACONW is less volatile compared to NXGN. This indicates lower risk in terms of short-term price fluctuations for ACONW.Check NXGN's competition here
Omada Health (NASDAQ: OMDA)
ACONW vs OMDA Comparison July 2026
Aclarion, Inc. (NASDAQ: ACONW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACONW stands at 11.7K. In comparison, OMDA has a market cap of 1.4B. Regarding current trading prices, ACONW is priced at $0.02 on the NASDAQ, while OMDA trades at $23.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACONW currently has a P/E ratio of N/A, whereas OMDA's P/E ratio is 338.57. In terms of profitability, ACONW's ROE is -0.54%, compared to OMDA's ROE of -0.03%. Regarding short-term risk, ACONW is less volatile compared to OMDA. This indicates lower risk in terms of short-term price fluctuations for ACONW.Check OMDA's competition here
Agiliti, Inc. (NYSE: AGTI)
ACONW vs AGTI Comparison July 2026
Aclarion, Inc. (NASDAQ: ACONW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACONW stands at 11.7K. In comparison, AGTI has a market cap of 1.4B. Regarding current trading prices, ACONW is priced at $0.02 on the NASDAQ, while AGTI trades at $10.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACONW currently has a P/E ratio of N/A, whereas AGTI's P/E ratio is -71.79. In terms of profitability, ACONW's ROE is -0.54%, compared to AGTI's ROE of -0.02%. Regarding short-term risk, ACONW is less volatile compared to AGTI. This indicates lower risk in terms of short-term price fluctuations for ACONW.Check AGTI's competition here
GoodRx Holdings, Inc. (NASDAQ: GDRX)
ACONW vs GDRX Comparison July 2026
Aclarion, Inc. (NASDAQ: ACONW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACONW stands at 11.7K. In comparison, GDRX has a market cap of 1.1B. Regarding current trading prices, ACONW is priced at $0.02 on the NASDAQ, while GDRX trades at $3.14.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACONW currently has a P/E ratio of N/A, whereas GDRX's P/E ratio is 9.52. In terms of profitability, ACONW's ROE is -0.54%, compared to GDRX's ROE of +0.03%. Regarding short-term risk, ACONW is less volatile compared to GDRX. This indicates lower risk in terms of short-term price fluctuations for ACONW.Check GDRX's competition here
Certara, Inc. (NASDAQ: CERT)
ACONW vs CERT Comparison July 2026
Aclarion, Inc. (NASDAQ: ACONW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACONW stands at 11.7K. In comparison, CERT has a market cap of 1.1B. Regarding current trading prices, ACONW is priced at $0.02 on the NASDAQ, while CERT trades at $6.93.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACONW currently has a P/E ratio of N/A, whereas CERT's P/E ratio is 17.77. In terms of profitability, ACONW's ROE is -0.54%, compared to CERT's ROE of -0.01%. Regarding short-term risk, ACONW is less volatile compared to CERT. This indicates lower risk in terms of short-term price fluctuations for ACONW.Check CERT's competition here
CareCloud, Inc. (NASDAQ: CCLDO)
ACONW vs CCLDO Comparison July 2026
Aclarion, Inc. (NASDAQ: ACONW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACONW stands at 11.7K. In comparison, CCLDO has a market cap of 857.3M. Regarding current trading prices, ACONW is priced at $0.02 on the NASDAQ, while CCLDO trades at $27.44.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACONW currently has a P/E ratio of N/A, whereas CCLDO's P/E ratio is N/A. In terms of profitability, ACONW's ROE is -0.54%, compared to CCLDO's ROE of +0.17%. Regarding short-term risk, ACONW is similarly volatile compared to CCLDO. This indicates similar risk in terms of short-term price fluctuations for ACONW.Check CCLDO's competition here
HealthStream, Inc. (NASDAQ: HSTM)
ACONW vs HSTM Comparison July 2026
Aclarion, Inc. (NASDAQ: ACONW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACONW stands at 11.7K. In comparison, HSTM has a market cap of 845.5M. Regarding current trading prices, ACONW is priced at $0.02 on the NASDAQ, while HSTM trades at $28.48.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACONW currently has a P/E ratio of N/A, whereas HSTM's P/E ratio is 38.08. In terms of profitability, ACONW's ROE is -0.54%, compared to HSTM's ROE of +0.06%. Regarding short-term risk, ACONW is less volatile compared to HSTM. This indicates lower risk in terms of short-term price fluctuations for ACONW.Check HSTM's competition here
GeneDx Holdings Corp. (NASDAQ: WGSWW)
ACONW vs WGSWW Comparison July 2026
Aclarion, Inc. (NASDAQ: ACONW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACONW stands at 11.7K. In comparison, WGSWW has a market cap of 748M. Regarding current trading prices, ACONW is priced at $0.02 on the NASDAQ, while WGSWW trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACONW currently has a P/E ratio of N/A, whereas WGSWW's P/E ratio is -0.02. In terms of profitability, ACONW's ROE is -0.54%, compared to WGSWW's ROE of -0.28%. Regarding short-term risk, ACONW is less volatile compared to WGSWW. This indicates lower risk in terms of short-term price fluctuations for ACONW.Check WGSWW's competition here
Phreesia, Inc. (NYSE: PHR)
ACONW vs PHR Comparison July 2026
Aclarion, Inc. (NASDAQ: ACONW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACONW stands at 11.7K. In comparison, PHR has a market cap of 662M. Regarding current trading prices, ACONW is priced at $0.02 on the NASDAQ, while PHR trades at $10.71.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACONW currently has a P/E ratio of N/A, whereas PHR's P/E ratio is 38.25. In terms of profitability, ACONW's ROE is -0.54%, compared to PHR's ROE of +0.03%. Regarding short-term risk, ACONW is less volatile compared to PHR. This indicates lower risk in terms of short-term price fluctuations for ACONW.Check PHR's competition here
Evolent Health, Inc. (NYSE: EVH)
ACONW vs EVH Comparison July 2026
Aclarion, Inc. (NASDAQ: ACONW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACONW stands at 11.7K. In comparison, EVH has a market cap of 652.4M. Regarding current trading prices, ACONW is priced at $0.02 on the NASDAQ, while EVH trades at $5.81.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACONW currently has a P/E ratio of N/A, whereas EVH's P/E ratio is 580.00. In terms of profitability, ACONW's ROE is -0.54%, compared to EVH's ROE of -0.78%. Regarding short-term risk, ACONW is less volatile compared to EVH. This indicates lower risk in terms of short-term price fluctuations for ACONW.Check EVH's competition here
MultiPlan Corporation (NYSE: MPLN-WT)
ACONW vs MPLN-WT Comparison July 2026
Aclarion, Inc. (NASDAQ: ACONW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACONW stands at 11.7K. In comparison, MPLN-WT has a market cap of 625.2M. Regarding current trading prices, ACONW is priced at $0.02 on the NASDAQ, while MPLN-WT trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACONW currently has a P/E ratio of N/A, whereas MPLN-WT's P/E ratio is N/A. In terms of profitability, ACONW's ROE is -0.54%, compared to MPLN-WT's ROE of +2.06%. Regarding short-term risk, ACONW is less volatile compared to MPLN-WT. This indicates lower risk in terms of short-term price fluctuations for ACONW.Check MPLN-WT's competition here
Accolade, Inc. (NASDAQ: ACCD)
ACONW vs ACCD Comparison July 2026
Aclarion, Inc. (NASDAQ: ACONW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACONW stands at 11.7K. In comparison, ACCD has a market cap of 575.6M. Regarding current trading prices, ACONW is priced at $0.02 on the NASDAQ, while ACCD trades at $7.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACONW currently has a P/E ratio of N/A, whereas ACCD's P/E ratio is -3.08. In terms of profitability, ACONW's ROE is -0.54%, compared to ACCD's ROE of -0.22%. Regarding short-term risk, ACONW is similarly volatile compared to ACCD. This indicates similar risk in terms of short-term price fluctuations for ACONW.Check ACCD's competition here
Sharecare, Inc. (NASDAQ: SHCR)
ACONW vs SHCR Comparison July 2026
Aclarion, Inc. (NASDAQ: ACONW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACONW stands at 11.7K. In comparison, SHCR has a market cap of 531.8M. Regarding current trading prices, ACONW is priced at $0.02 on the NASDAQ, while SHCR trades at $1.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACONW currently has a P/E ratio of N/A, whereas SHCR's P/E ratio is -3.76. In terms of profitability, ACONW's ROE is -0.54%, compared to SHCR's ROE of -0.25%. Regarding short-term risk, ACONW is less volatile compared to SHCR. This indicates lower risk in terms of short-term price fluctuations for ACONW.Check SHCR's competition here
Claritev Corporation (NYSE: CTEV)
ACONW vs CTEV Comparison July 2026
Aclarion, Inc. (NASDAQ: ACONW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACONW stands at 11.7K. In comparison, CTEV has a market cap of 517.5M. Regarding current trading prices, ACONW is priced at $0.02 on the NASDAQ, while CTEV trades at $30.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACONW currently has a P/E ratio of N/A, whereas CTEV's P/E ratio is -2.33. In terms of profitability, ACONW's ROE is -0.54%, compared to CTEV's ROE of +2.06%. Regarding short-term risk, ACONW is less volatile compared to CTEV. This indicates lower risk in terms of short-term price fluctuations for ACONW.Check CTEV's competition here
NRC Health (NASDAQ: NRC)
ACONW vs NRC Comparison July 2026
Aclarion, Inc. (NASDAQ: ACONW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACONW stands at 11.7K. In comparison, NRC has a market cap of 490.8M. Regarding current trading prices, ACONW is priced at $0.02 on the NASDAQ, while NRC trades at $21.78.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACONW currently has a P/E ratio of N/A, whereas NRC's P/E ratio is 26.56. In terms of profitability, ACONW's ROE is -0.54%, compared to NRC's ROE of +0.57%. Regarding short-term risk, ACONW is less volatile compared to NRC. This indicates lower risk in terms of short-term price fluctuations for ACONW.Check NRC's competition here
SOPHiA GENETICS S.A. (NASDAQ: SOPH)
ACONW vs SOPH Comparison July 2026
Aclarion, Inc. (NASDAQ: ACONW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACONW stands at 11.7K. In comparison, SOPH has a market cap of 403.5M. Regarding current trading prices, ACONW is priced at $0.02 on the NASDAQ, while SOPH trades at $5.87.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACONW currently has a P/E ratio of N/A, whereas SOPH's P/E ratio is -11.29. In terms of profitability, ACONW's ROE is -0.54%, compared to SOPH's ROE of -1.41%. Regarding short-term risk, ACONW is less volatile compared to SOPH. This indicates lower risk in terms of short-term price fluctuations for ACONW.Check SOPH's competition here
SomaLogic, Inc. (NASDAQ: SLGCW)
ACONW vs SLGCW Comparison July 2026
Aclarion, Inc. (NASDAQ: ACONW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACONW stands at 11.7K. In comparison, SLGCW has a market cap of 396.2M. Regarding current trading prices, ACONW is priced at $0.02 on the NASDAQ, while SLGCW trades at $0.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACONW currently has a P/E ratio of N/A, whereas SLGCW's P/E ratio is -0.16. In terms of profitability, ACONW's ROE is -0.54%, compared to SLGCW's ROE of -0.19%. Regarding short-term risk, ACONW is less volatile compared to SLGCW. This indicates lower risk in terms of short-term price fluctuations for ACONW.Check SLGCW's competition here
SomaLogic, Inc. (NASDAQ: SLGC)
ACONW vs SLGC Comparison July 2026
Aclarion, Inc. (NASDAQ: ACONW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACONW stands at 11.7K. In comparison, SLGC has a market cap of 396.2M. Regarding current trading prices, ACONW is priced at $0.02 on the NASDAQ, while SLGC trades at $2.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACONW currently has a P/E ratio of N/A, whereas SLGC's P/E ratio is -3.04. In terms of profitability, ACONW's ROE is -0.54%, compared to SLGC's ROE of -0.19%. Regarding short-term risk, ACONW is less volatile compared to SLGC. This indicates lower risk in terms of short-term price fluctuations for ACONW.Check SLGC's competition here
TruBridge, Inc. (NASDAQ: TBRG)
ACONW vs TBRG Comparison July 2026
Aclarion, Inc. (NASDAQ: ACONW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACONW stands at 11.7K. In comparison, TBRG has a market cap of 393.6M. Regarding current trading prices, ACONW is priced at $0.02 on the NASDAQ, while TBRG trades at $26.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACONW currently has a P/E ratio of N/A, whereas TBRG's P/E ratio is 9.37. In terms of profitability, ACONW's ROE is -0.54%, compared to TBRG's ROE of +0.02%. Regarding short-term risk, ACONW is less volatile compared to TBRG. This indicates lower risk in terms of short-term price fluctuations for ACONW.Check TBRG's competition here
MultiPlan Corporation (NYSE: MPLN)
ACONW vs MPLN Comparison July 2026
Aclarion, Inc. (NASDAQ: ACONW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACONW stands at 11.7K. In comparison, MPLN has a market cap of 375M. Regarding current trading prices, ACONW is priced at $0.02 on the NASDAQ, while MPLN trades at $23.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACONW currently has a P/E ratio of N/A, whereas MPLN's P/E ratio is -0.23. In terms of profitability, ACONW's ROE is -0.54%, compared to MPLN's ROE of +2.06%. Regarding short-term risk, ACONW is less volatile compared to MPLN. This indicates lower risk in terms of short-term price fluctuations for ACONW.Check MPLN's competition here
Simulations Plus, Inc. (NASDAQ: SLP)
ACONW vs SLP Comparison July 2026
Aclarion, Inc. (NASDAQ: ACONW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACONW stands at 11.7K. In comparison, SLP has a market cap of 368.7M. Regarding current trading prices, ACONW is priced at $0.02 on the NASDAQ, while SLP trades at $18.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACONW currently has a P/E ratio of N/A, whereas SLP's P/E ratio is 20.72. In terms of profitability, ACONW's ROE is -0.54%, compared to SLP's ROE of +0.06%. Regarding short-term risk, ACONW is less volatile compared to SLP. This indicates lower risk in terms of short-term price fluctuations for ACONW.Check SLP's competition here
Tabula Rasa HealthCare, Inc. (NASDAQ: TRHC)
ACONW vs TRHC Comparison July 2026
Aclarion, Inc. (NASDAQ: ACONW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACONW stands at 11.7K. In comparison, TRHC has a market cap of 284M. Regarding current trading prices, ACONW is priced at $0.02 on the NASDAQ, while TRHC trades at $10.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACONW currently has a P/E ratio of N/A, whereas TRHC's P/E ratio is -4.27. In terms of profitability, ACONW's ROE is -0.54%, compared to TRHC's ROE of +121.31%. Regarding short-term risk, ACONW is less volatile compared to TRHC. This indicates lower risk in terms of short-term price fluctuations for ACONW.Check TRHC's competition here
Sema4 Holdings Corp. (NASDAQ: SMFR)
ACONW vs SMFR Comparison July 2026
Aclarion, Inc. (NASDAQ: ACONW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACONW stands at 11.7K. In comparison, SMFR has a market cap of 246.4M. Regarding current trading prices, ACONW is priced at $0.02 on the NASDAQ, while SMFR trades at $0.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACONW currently has a P/E ratio of N/A, whereas SMFR's P/E ratio is N/A. In terms of profitability, ACONW's ROE is -0.54%, compared to SMFR's ROE of -0.28%. Regarding short-term risk, ACONW is less volatile compared to SMFR. This indicates lower risk in terms of short-term price fluctuations for ACONW.Check SMFR's competition here
Spok Holdings, Inc. (NASDAQ: SPOK)
ACONW vs SPOK Comparison July 2026
Aclarion, Inc. (NASDAQ: ACONW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACONW stands at 11.7K. In comparison, SPOK has a market cap of 222.2M. Regarding current trading prices, ACONW is priced at $0.02 on the NASDAQ, while SPOK trades at $10.64.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACONW currently has a P/E ratio of N/A, whereas SPOK's P/E ratio is 17.73. In terms of profitability, ACONW's ROE is -0.54%, compared to SPOK's ROE of +0.09%. Regarding short-term risk, ACONW is less volatile compared to SPOK. This indicates lower risk in terms of short-term price fluctuations for ACONW.Check SPOK's competition here
So-Young International Inc. (NASDAQ: SY)
ACONW vs SY Comparison July 2026
Aclarion, Inc. (NASDAQ: ACONW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACONW stands at 11.7K. In comparison, SY has a market cap of 220.4M. Regarding current trading prices, ACONW is priced at $0.02 on the NASDAQ, while SY trades at $1.68.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACONW currently has a P/E ratio of N/A, whereas SY's P/E ratio is -5.09. In terms of profitability, ACONW's ROE is -0.54%, compared to SY's ROE of -0.16%. Regarding short-term risk, ACONW is less volatile compared to SY. This indicates lower risk in terms of short-term price fluctuations for ACONW.Check SY's competition here
American Well Corporation (NYSE: AMWL)
ACONW vs AMWL Comparison July 2026
Aclarion, Inc. (NASDAQ: ACONW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACONW stands at 11.7K. In comparison, AMWL has a market cap of 220.3M. Regarding current trading prices, ACONW is priced at $0.02 on the NASDAQ, while AMWL trades at $13.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACONW currently has a P/E ratio of N/A, whereas AMWL's P/E ratio is -2.54. In terms of profitability, ACONW's ROE is -0.54%, compared to AMWL's ROE of -0.35%. Regarding short-term risk, ACONW is less volatile compared to AMWL. This indicates lower risk in terms of short-term price fluctuations for ACONW.Check AMWL's competition here
Health Catalyst, Inc. (NASDAQ: HCAT)
ACONW vs HCAT Comparison July 2026
Aclarion, Inc. (NASDAQ: ACONW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACONW stands at 11.7K. In comparison, HCAT has a market cap of 166.3M. Regarding current trading prices, ACONW is priced at $0.02 on the NASDAQ, while HCAT trades at $2.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACONW currently has a P/E ratio of N/A, whereas HCAT's P/E ratio is 11.25. In terms of profitability, ACONW's ROE is -0.54%, compared to HCAT's ROE of -1.00%. Regarding short-term risk, ACONW is less volatile compared to HCAT. This indicates lower risk in terms of short-term price fluctuations for ACONW.Check HCAT's competition here
Computer Programs and Systems, Inc. (NASDAQ: CPSI)
ACONW vs CPSI Comparison July 2026
Aclarion, Inc. (NASDAQ: ACONW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACONW stands at 11.7K. In comparison, CPSI has a market cap of 133.7M. Regarding current trading prices, ACONW is priced at $0.02 on the NASDAQ, while CPSI trades at $9.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACONW currently has a P/E ratio of N/A, whereas CPSI's P/E ratio is -183.80. In terms of profitability, ACONW's ROE is -0.54%, compared to CPSI's ROE of +0.02%. Regarding short-term risk, ACONW is less volatile compared to CPSI. This indicates lower risk in terms of short-term price fluctuations for ACONW.Check CPSI's competition here
OptimizeRx Corp. (NASDAQ: OPRX)
ACONW vs OPRX Comparison July 2026
Aclarion, Inc. (NASDAQ: ACONW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACONW stands at 11.7K. In comparison, OPRX has a market cap of 125.5M. Regarding current trading prices, ACONW is priced at $0.02 on the NASDAQ, while OPRX trades at $6.69.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACONW currently has a P/E ratio of N/A, whereas OPRX's P/E ratio is 6.14. In terms of profitability, ACONW's ROE is -0.54%, compared to OPRX's ROE of +0.05%. Regarding short-term risk, ACONW is less volatile compared to OPRX. This indicates lower risk in terms of short-term price fluctuations for ACONW.Check OPRX's competition here
Augmedix, Inc. (NASDAQ: AUGX)
ACONW vs AUGX Comparison July 2026
Aclarion, Inc. (NASDAQ: ACONW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACONW stands at 11.7K. In comparison, AUGX has a market cap of 115.9M. Regarding current trading prices, ACONW is priced at $0.02 on the NASDAQ, while AUGX trades at $2.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACONW currently has a P/E ratio of N/A, whereas AUGX's P/E ratio is -4.99. In terms of profitability, ACONW's ROE is -0.54%, compared to AUGX's ROE of -1.55%. Regarding short-term risk, ACONW is less volatile compared to AUGX. This indicates lower risk in terms of short-term price fluctuations for ACONW.Check AUGX's competition here
CareCloud, Inc. (NASDAQ: CCLD)
ACONW vs CCLD Comparison July 2026
Aclarion, Inc. (NASDAQ: ACONW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACONW stands at 11.7K. In comparison, CCLD has a market cap of 98.6M. Regarding current trading prices, ACONW is priced at $0.02 on the NASDAQ, while CCLD trades at $2.32.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACONW currently has a P/E ratio of N/A, whereas CCLD's P/E ratio is 8.59. In terms of profitability, ACONW's ROE is -0.54%, compared to CCLD's ROE of +0.17%. Regarding short-term risk, ACONW is less volatile compared to CCLD. This indicates lower risk in terms of short-term price fluctuations for ACONW.Check CCLD's competition here
Definitive Healthcare Corp. (NASDAQ: DH)
ACONW vs DH Comparison July 2026
Aclarion, Inc. (NASDAQ: ACONW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACONW stands at 11.7K. In comparison, DH has a market cap of 80.1M. Regarding current trading prices, ACONW is priced at $0.02 on the NASDAQ, while DH trades at $0.76.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACONW currently has a P/E ratio of N/A, whereas DH's P/E ratio is 2.92. In terms of profitability, ACONW's ROE is -0.54%, compared to DH's ROE of -0.67%. Regarding short-term risk, ACONW is less volatile compared to DH. This indicates lower risk in terms of short-term price fluctuations for ACONW.Check DH's competition here
Forian Inc. (NASDAQ: FORA)
ACONW vs FORA Comparison July 2026
Aclarion, Inc. (NASDAQ: ACONW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACONW stands at 11.7K. In comparison, FORA has a market cap of 67.8M. Regarding current trading prices, ACONW is priced at $0.02 on the NASDAQ, while FORA trades at $2.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACONW currently has a P/E ratio of N/A, whereas FORA's P/E ratio is -24.11. In terms of profitability, ACONW's ROE is -0.54%, compared to FORA's ROE of -0.17%. Regarding short-term risk, ACONW is similarly volatile compared to FORA. This indicates similar risk in terms of short-term price fluctuations for ACONW.Check FORA's competition here
CareCloud, Inc. (NASDAQ: CCLDP)
ACONW vs CCLDP Comparison July 2026
Aclarion, Inc. (NASDAQ: ACONW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACONW stands at 11.7K. In comparison, CCLDP has a market cap of 59.9M. Regarding current trading prices, ACONW is priced at $0.02 on the NASDAQ, while CCLDP trades at $19.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACONW currently has a P/E ratio of N/A, whereas CCLDP's P/E ratio is N/A. In terms of profitability, ACONW's ROE is -0.54%, compared to CCLDP's ROE of +0.17%. Regarding short-term risk, ACONW is less volatile compared to CCLDP. This indicates lower risk in terms of short-term price fluctuations for ACONW.Check CCLDP's competition here
OneMedNet Corporation (NASDAQ: ONMD)
ACONW vs ONMD Comparison July 2026
Aclarion, Inc. (NASDAQ: ACONW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACONW stands at 11.7K. In comparison, ONMD has a market cap of 38.7M. Regarding current trading prices, ACONW is priced at $0.02 on the NASDAQ, while ONMD trades at $0.68.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACONW currently has a P/E ratio of N/A, whereas ONMD's P/E ratio is -4.53. In terms of profitability, ACONW's ROE is -0.54%, compared to ONMD's ROE of +0.90%. Regarding short-term risk, ACONW is less volatile compared to ONMD. This indicates lower risk in terms of short-term price fluctuations for ACONW.Check ONMD's competition here
Science 37 Holdings, Inc. (NASDAQ: SNCE)
ACONW vs SNCE Comparison July 2026
Aclarion, Inc. (NASDAQ: ACONW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACONW stands at 11.7K. In comparison, SNCE has a market cap of 34.7M. Regarding current trading prices, ACONW is priced at $0.02 on the NASDAQ, while SNCE trades at $5.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACONW currently has a P/E ratio of N/A, whereas SNCE's P/E ratio is -0.27. In terms of profitability, ACONW's ROE is -0.54%, compared to SNCE's ROE of -0.47%. Regarding short-term risk, ACONW is less volatile compared to SNCE. This indicates lower risk in terms of short-term price fluctuations for ACONW.Check SNCE's competition here
Akili, Inc. (NASDAQ: AKLI)
ACONW vs AKLI Comparison July 2026
Aclarion, Inc. (NASDAQ: ACONW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACONW stands at 11.7K. In comparison, AKLI has a market cap of 34.1M. Regarding current trading prices, ACONW is priced at $0.02 on the NASDAQ, while AKLI trades at $0.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACONW currently has a P/E ratio of N/A, whereas AKLI's P/E ratio is -0.71. In terms of profitability, ACONW's ROE is -0.54%, compared to AKLI's ROE of -0.70%. Regarding short-term risk, ACONW is less volatile compared to AKLI. This indicates lower risk in terms of short-term price fluctuations for ACONW.Check AKLI's competition here
SHL Telemedicine Ltd. (NASDAQ: SHLT)
ACONW vs SHLT Comparison July 2026
Aclarion, Inc. (NASDAQ: ACONW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACONW stands at 11.7K. In comparison, SHLT has a market cap of 33.6M. Regarding current trading prices, ACONW is priced at $0.02 on the NASDAQ, while SHLT trades at $2.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACONW currently has a P/E ratio of N/A, whereas SHLT's P/E ratio is -3.87. In terms of profitability, ACONW's ROE is -0.54%, compared to SHLT's ROE of -0.50%. Regarding short-term risk, ACONW is similarly volatile compared to SHLT. This indicates similar risk in terms of short-term price fluctuations for ACONW.Check SHLT's competition here
Sharecare, Inc. (NASDAQ: SHCRW)
ACONW vs SHCRW Comparison July 2026
Aclarion, Inc. (NASDAQ: ACONW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACONW stands at 11.7K. In comparison, SHCRW has a market cap of 32.5M. Regarding current trading prices, ACONW is priced at $0.02 on the NASDAQ, while SHCRW trades at $0.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACONW currently has a P/E ratio of N/A, whereas SHCRW's P/E ratio is -0.00. In terms of profitability, ACONW's ROE is -0.54%, compared to SHCRW's ROE of -0.25%. Regarding short-term risk, ACONW is less volatile compared to SHCRW. This indicates lower risk in terms of short-term price fluctuations for ACONW.Check SHCRW's competition here
OneMedNet Corporation (NASDAQ: ONMDW)
ACONW vs ONMDW Comparison July 2026
Aclarion, Inc. (NASDAQ: ACONW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACONW stands at 11.7K. In comparison, ONMDW has a market cap of 27.7M. Regarding current trading prices, ACONW is priced at $0.02 on the NASDAQ, while ONMDW trades at $0.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACONW currently has a P/E ratio of N/A, whereas ONMDW's P/E ratio is N/A. In terms of profitability, ACONW's ROE is -0.54%, compared to ONMDW's ROE of +0.90%. Regarding short-term risk, ACONW is similarly volatile compared to ONMDW. This indicates similar risk in terms of short-term price fluctuations for ACONW.Check ONMDW's competition here
Streamline Health Solutions, Inc. (NASDAQ: STRM)
ACONW vs STRM Comparison July 2026
Aclarion, Inc. (NASDAQ: ACONW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACONW stands at 11.7K. In comparison, STRM has a market cap of 23.2M. Regarding current trading prices, ACONW is priced at $0.02 on the NASDAQ, while STRM trades at $5.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACONW currently has a P/E ratio of N/A, whereas STRM's P/E ratio is -2.40. In terms of profitability, ACONW's ROE is -0.54%, compared to STRM's ROE of -0.32%. Regarding short-term risk, ACONW is similarly volatile compared to STRM. This indicates similar risk in terms of short-term price fluctuations for ACONW.Check STRM's competition here
Renalytix Plc (NASDAQ: RNLX)
ACONW vs RNLX Comparison July 2026
Aclarion, Inc. (NASDAQ: ACONW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACONW stands at 11.7K. In comparison, RNLX has a market cap of 22.5M. Regarding current trading prices, ACONW is priced at $0.02 on the NASDAQ, while RNLX trades at $0.21.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACONW currently has a P/E ratio of N/A, whereas RNLX's P/E ratio is -0.33. In terms of profitability, ACONW's ROE is -0.54%, compared to RNLX's ROE of -6.31%. Regarding short-term risk, ACONW is less volatile compared to RNLX. This indicates lower risk in terms of short-term price fluctuations for ACONW.Check RNLX's competition here
MSP Recovery, Inc. (NASDAQ: LIFW)
ACONW vs LIFW Comparison July 2026
Aclarion, Inc. (NASDAQ: ACONW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACONW stands at 11.7K. In comparison, LIFW has a market cap of 22.4M. Regarding current trading prices, ACONW is priced at $0.02 on the NASDAQ, while LIFW trades at $3.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACONW currently has a P/E ratio of N/A, whereas LIFW's P/E ratio is -0.02. In terms of profitability, ACONW's ROE is -0.54%, compared to LIFW's ROE of +1.56%. Regarding short-term risk, ACONW is similarly volatile compared to LIFW. This indicates similar risk in terms of short-term price fluctuations for ACONW.Check LIFW's competition here
EUDA Health Holdings Limited (NASDAQ: EUDA)
ACONW vs EUDA Comparison July 2026
Aclarion, Inc. (NASDAQ: ACONW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACONW stands at 11.7K. In comparison, EUDA has a market cap of 21.1M. Regarding current trading prices, ACONW is priced at $0.02 on the NASDAQ, while EUDA trades at $11.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACONW currently has a P/E ratio of N/A, whereas EUDA's P/E ratio is -21.32. In terms of profitability, ACONW's ROE is -0.54%, compared to EUDA's ROE of +0.70%. Regarding short-term risk, ACONW is less volatile compared to EUDA. This indicates lower risk in terms of short-term price fluctuations for ACONW.Check EUDA's competition here
Babylon Holdings Limited (NYSE: BBLN)
ACONW vs BBLN Comparison July 2026
Aclarion, Inc. (NASDAQ: ACONW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACONW stands at 11.7K. In comparison, BBLN has a market cap of 14.1M. Regarding current trading prices, ACONW is priced at $0.02 on the NASDAQ, while BBLN trades at $0.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACONW currently has a P/E ratio of N/A, whereas BBLN's P/E ratio is -0.04. In terms of profitability, ACONW's ROE is -0.54%, compared to BBLN's ROE of +4.89%. Regarding short-term risk, ACONW is less volatile compared to BBLN. This indicates lower risk in terms of short-term price fluctuations for ACONW.Check BBLN's competition here
HeartBeam, Inc. (NASDAQ: BEATW)
ACONW vs BEATW Comparison July 2026
Aclarion, Inc. (NASDAQ: ACONW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACONW stands at 11.7K. In comparison, BEATW has a market cap of 13.4M. Regarding current trading prices, ACONW is priced at $0.02 on the NASDAQ, while BEATW trades at $0.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACONW currently has a P/E ratio of N/A, whereas BEATW's P/E ratio is -0.04. In terms of profitability, ACONW's ROE is -0.54%, compared to BEATW's ROE of -10.34%. Regarding short-term risk, ACONW is less volatile compared to BEATW. This indicates lower risk in terms of short-term price fluctuations for ACONW.Check BEATW's competition here
ETAO International Co., Ltd. (NASDAQ: ETAO)
ACONW vs ETAO Comparison July 2026
Aclarion, Inc. (NASDAQ: ACONW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACONW stands at 11.7K. In comparison, ETAO has a market cap of 9.8M. Regarding current trading prices, ACONW is priced at $0.02 on the NASDAQ, while ETAO trades at $1.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACONW currently has a P/E ratio of N/A, whereas ETAO's P/E ratio is -0.01. In terms of profitability, ACONW's ROE is -0.54%, compared to ETAO's ROE of -13.69%. Regarding short-term risk, ACONW is less volatile compared to ETAO. This indicates lower risk in terms of short-term price fluctuations for ACONW.Check ETAO's competition here
Bullfrog AI Holdings, Inc. Common Stock (NASDAQ: BFRG)
ACONW vs BFRG Comparison July 2026
Aclarion, Inc. (NASDAQ: ACONW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACONW stands at 11.7K. In comparison, BFRG has a market cap of 7.5M. Regarding current trading prices, ACONW is priced at $0.02 on the NASDAQ, while BFRG trades at $0.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACONW currently has a P/E ratio of N/A, whereas BFRG's P/E ratio is -1.20. In terms of profitability, ACONW's ROE is -0.54%, compared to BFRG's ROE of -2.18%. Regarding short-term risk, ACONW is less volatile compared to BFRG. This indicates lower risk in terms of short-term price fluctuations for ACONW.Check BFRG's competition here
Cue Health Inc. (NASDAQ: HLTH)
ACONW vs HLTH Comparison July 2026
Aclarion, Inc. (NASDAQ: ACONW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACONW stands at 11.7K. In comparison, HLTH has a market cap of 6.9M. Regarding current trading prices, ACONW is priced at $0.02 on the NASDAQ, while HLTH trades at $0.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACONW currently has a P/E ratio of N/A, whereas HLTH's P/E ratio is -0.02. In terms of profitability, ACONW's ROE is -0.54%, compared to HLTH's ROE of -0.90%. Regarding short-term risk, ACONW is less volatile compared to HLTH. This indicates lower risk in terms of short-term price fluctuations for ACONW.Check HLTH's competition here
Scienture Holdings, Inc. (NASDAQ: SCNX)
ACONW vs SCNX Comparison July 2026
Aclarion, Inc. (NASDAQ: ACONW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACONW stands at 11.7K. In comparison, SCNX has a market cap of 6.4M. Regarding current trading prices, ACONW is priced at $0.02 on the NASDAQ, while SCNX trades at $0.41.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACONW currently has a P/E ratio of N/A, whereas SCNX's P/E ratio is -0.16. In terms of profitability, ACONW's ROE is -0.54%, compared to SCNX's ROE of -0.00%. Regarding short-term risk, ACONW is less volatile compared to SCNX. This indicates lower risk in terms of short-term price fluctuations for ACONW.Check SCNX's competition here
UpHealth, Inc. (NYSE: UPH)
ACONW vs UPH Comparison July 2026
Aclarion, Inc. (NASDAQ: ACONW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACONW stands at 11.7K. In comparison, UPH has a market cap of 5.3M. Regarding current trading prices, ACONW is priced at $0.02 on the NASDAQ, while UPH trades at $0.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACONW currently has a P/E ratio of N/A, whereas UPH's P/E ratio is -0.07. In terms of profitability, ACONW's ROE is -0.54%, compared to UPH's ROE of -1.05%. Regarding short-term risk, ACONW is less volatile compared to UPH. This indicates lower risk in terms of short-term price fluctuations for ACONW.Check UPH's competition here
UpHealth, Inc. (NYSE: UPH-WT)
ACONW vs UPH-WT Comparison July 2026
Aclarion, Inc. (NASDAQ: ACONW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACONW stands at 11.7K. In comparison, UPH-WT has a market cap of 5.3M. Regarding current trading prices, ACONW is priced at $0.02 on the NASDAQ, while UPH-WT trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACONW currently has a P/E ratio of N/A, whereas UPH-WT's P/E ratio is N/A. In terms of profitability, ACONW's ROE is -0.54%, compared to UPH-WT's ROE of -1.05%. Regarding short-term risk, ACONW is less volatile compared to UPH-WT. This indicates lower risk in terms of short-term price fluctuations for ACONW.Check UPH-WT's competition here
Mangoceuticals, Inc. (NASDAQ: MGRX)
ACONW vs MGRX Comparison July 2026
Aclarion, Inc. (NASDAQ: ACONW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACONW stands at 11.7K. In comparison, MGRX has a market cap of 4.2M. Regarding current trading prices, ACONW is priced at $0.02 on the NASDAQ, while MGRX trades at $0.41.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACONW currently has a P/E ratio of N/A, whereas MGRX's P/E ratio is -0.31. In terms of profitability, ACONW's ROE is -0.54%, compared to MGRX's ROE of -1.21%. Regarding short-term risk, ACONW is less volatile compared to MGRX. This indicates lower risk in terms of short-term price fluctuations for ACONW.Check MGRX's competition here
Pear Therapeutics, Inc. (NASDAQ: PEAR)
ACONW vs PEAR Comparison July 2026
Aclarion, Inc. (NASDAQ: ACONW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACONW stands at 11.7K. In comparison, PEAR has a market cap of 4.1M. Regarding current trading prices, ACONW is priced at $0.02 on the NASDAQ, while PEAR trades at $0.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACONW currently has a P/E ratio of N/A, whereas PEAR's P/E ratio is -0.08. In terms of profitability, ACONW's ROE is -0.54%, compared to PEAR's ROE of -0.39%. Regarding short-term risk, ACONW is less volatile compared to PEAR. This indicates lower risk in terms of short-term price fluctuations for ACONW.Check PEAR's competition here
Pear Therapeutics, Inc. (NASDAQ: PEARW)
ACONW vs PEARW Comparison July 2026
Aclarion, Inc. (NASDAQ: ACONW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACONW stands at 11.7K. In comparison, PEARW has a market cap of 4.1M. Regarding current trading prices, ACONW is priced at $0.02 on the NASDAQ, while PEARW trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACONW currently has a P/E ratio of N/A, whereas PEARW's P/E ratio is -0.00. In terms of profitability, ACONW's ROE is -0.54%, compared to PEARW's ROE of -0.39%. Regarding short-term risk, ACONW is less volatile compared to PEARW. This indicates lower risk in terms of short-term price fluctuations for ACONW.Check PEARW's competition here
Ontrak, Inc. (NASDAQ: OTRK)
ACONW vs OTRK Comparison July 2026
Aclarion, Inc. (NASDAQ: ACONW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACONW stands at 11.7K. In comparison, OTRK has a market cap of 2.3M. Regarding current trading prices, ACONW is priced at $0.02 on the NASDAQ, while OTRK trades at $0.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACONW currently has a P/E ratio of N/A, whereas OTRK's P/E ratio is -0.02. In terms of profitability, ACONW's ROE is -0.54%, compared to OTRK's ROE of -2.11%. Regarding short-term risk, ACONW is similarly volatile compared to OTRK. This indicates similar risk in terms of short-term price fluctuations for ACONW.Check OTRK's competition here
VSee Health, Inc. (NASDAQ: VSEEW)
ACONW vs VSEEW Comparison July 2026
Aclarion, Inc. (NASDAQ: ACONW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACONW stands at 11.7K. In comparison, VSEEW has a market cap of 2.2M. Regarding current trading prices, ACONW is priced at $0.02 on the NASDAQ, while VSEEW trades at $0.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACONW currently has a P/E ratio of N/A, whereas VSEEW's P/E ratio is -0.06. In terms of profitability, ACONW's ROE is -0.54%, compared to VSEEW's ROE of -115.71%. Regarding short-term risk, ACONW is similarly volatile compared to VSEEW. This indicates similar risk in terms of short-term price fluctuations for ACONW.Check VSEEW's competition here
Healthcare Triangle, Inc. (NASDAQ: HCTI)
ACONW vs HCTI Comparison July 2026
Aclarion, Inc. (NASDAQ: ACONW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACONW stands at 11.7K. In comparison, HCTI has a market cap of 2.1M. Regarding current trading prices, ACONW is priced at $0.02 on the NASDAQ, while HCTI trades at $1.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACONW currently has a P/E ratio of N/A, whereas HCTI's P/E ratio is -0.23. In terms of profitability, ACONW's ROE is -0.54%, compared to HCTI's ROE of -0.68%. Regarding short-term risk, ACONW is less volatile compared to HCTI. This indicates lower risk in terms of short-term price fluctuations for ACONW.Check HCTI's competition here
CareMax, Inc. (NASDAQ: CMAX)
ACONW vs CMAX Comparison July 2026
Aclarion, Inc. (NASDAQ: ACONW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACONW stands at 11.7K. In comparison, CMAX has a market cap of 1.6M. Regarding current trading prices, ACONW is priced at $0.02 on the NASDAQ, while CMAX trades at $0.42.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACONW currently has a P/E ratio of N/A, whereas CMAX's P/E ratio is -0.00. In terms of profitability, ACONW's ROE is -0.54%, compared to CMAX's ROE of -2.01%. Regarding short-term risk, ACONW is similarly volatile compared to CMAX. This indicates similar risk in terms of short-term price fluctuations for ACONW.Check CMAX's competition here
VSee Health, Inc. (NASDAQ: VSEE)
ACONW vs VSEE Comparison July 2026
Aclarion, Inc. (NASDAQ: ACONW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACONW stands at 11.7K. In comparison, VSEE has a market cap of 1.6M. Regarding current trading prices, ACONW is priced at $0.02 on the NASDAQ, while VSEE trades at $0.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACONW currently has a P/E ratio of N/A, whereas VSEE's P/E ratio is -0.19. In terms of profitability, ACONW's ROE is -0.54%, compared to VSEE's ROE of -115.71%. Regarding short-term risk, ACONW is less volatile compared to VSEE. This indicates lower risk in terms of short-term price fluctuations for ACONW.Check VSEE's competition here
Aclarion, Inc. (NASDAQ: ACON)
ACONW vs ACON Comparison July 2026
Aclarion, Inc. (NASDAQ: ACONW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACONW stands at 11.7K. In comparison, ACON has a market cap of 1.3M. Regarding current trading prices, ACONW is priced at $0.02 on the NASDAQ, while ACON trades at $2.58.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACONW currently has a P/E ratio of N/A, whereas ACON's P/E ratio is -0.24. In terms of profitability, ACONW's ROE is -0.54%, compared to ACON's ROE of -0.54%. Regarding short-term risk, ACONW is less volatile compared to ACON. This indicates lower risk in terms of short-term price fluctuations for ACONW.Check ACON's competition here
MSP Recovery, Inc. (NASDAQ: LIFWZ)
ACONW vs LIFWZ Comparison July 2026
Aclarion, Inc. (NASDAQ: ACONW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACONW stands at 11.7K. In comparison, LIFWZ has a market cap of 1.3M. Regarding current trading prices, ACONW is priced at $0.02 on the NASDAQ, while LIFWZ trades at $0.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACONW currently has a P/E ratio of N/A, whereas LIFWZ's P/E ratio is N/A. In terms of profitability, ACONW's ROE is -0.54%, compared to LIFWZ's ROE of +1.56%. Regarding short-term risk, ACONW is similarly volatile compared to LIFWZ. This indicates similar risk in terms of short-term price fluctuations for ACONW.Check LIFWZ's competition here
EUDA Health Holdings Limited (NASDAQ: EUDAW)
ACONW vs EUDAW Comparison July 2026
Aclarion, Inc. (NASDAQ: ACONW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACONW stands at 11.7K. In comparison, EUDAW has a market cap of 926.3K. Regarding current trading prices, ACONW is priced at $0.02 on the NASDAQ, while EUDAW trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACONW currently has a P/E ratio of N/A, whereas EUDAW's P/E ratio is 0.03. In terms of profitability, ACONW's ROE is -0.54%, compared to EUDAW's ROE of +0.70%. Regarding short-term risk, ACONW is less volatile compared to EUDAW. This indicates lower risk in terms of short-term price fluctuations for ACONW.Check EUDAW's competition here
SCWorx Corp. (NASDAQ: WORX)
ACONW vs WORX Comparison July 2026
Aclarion, Inc. (NASDAQ: ACONW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACONW stands at 11.7K. In comparison, WORX has a market cap of 693.4K. Regarding current trading prices, ACONW is priced at $0.02 on the NASDAQ, while WORX trades at $0.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACONW currently has a P/E ratio of N/A, whereas WORX's P/E ratio is -0.76. In terms of profitability, ACONW's ROE is -0.54%, compared to WORX's ROE of -0.65%. Regarding short-term risk, ACONW is similarly volatile compared to WORX. This indicates similar risk in terms of short-term price fluctuations for ACONW.Check WORX's competition here
MSP Recovery, Inc. (NASDAQ: MSPRZ)
ACONW vs MSPRZ Comparison July 2026
Aclarion, Inc. (NASDAQ: ACONW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACONW stands at 11.7K. In comparison, MSPRZ has a market cap of 550.4K. Regarding current trading prices, ACONW is priced at $0.02 on the NASDAQ, while MSPRZ trades at $0.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACONW currently has a P/E ratio of N/A, whereas MSPRZ's P/E ratio is N/A. In terms of profitability, ACONW's ROE is -0.54%, compared to MSPRZ's ROE of +1.56%. Regarding short-term risk, ACONW is less volatile compared to MSPRZ. This indicates lower risk in terms of short-term price fluctuations for ACONW.Check MSPRZ's competition here
Akerna Corp. (NASDAQ: KERN)
ACONW vs KERN Comparison July 2026
Aclarion, Inc. (NASDAQ: ACONW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACONW stands at 11.7K. In comparison, KERN has a market cap of 162.3K. Regarding current trading prices, ACONW is priced at $0.02 on the NASDAQ, while KERN trades at $0.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACONW currently has a P/E ratio of N/A, whereas KERN's P/E ratio is -0.01. In terms of profitability, ACONW's ROE is -0.54%, compared to KERN's ROE of -0.17%. Regarding short-term risk, ACONW is less volatile compared to KERN. This indicates lower risk in terms of short-term price fluctuations for ACONW.Check KERN's competition here
Akerna Corp. (NASDAQ: KERNW)
ACONW vs KERNW Comparison July 2026
Aclarion, Inc. (NASDAQ: ACONW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACONW stands at 11.7K. In comparison, KERNW has a market cap of 162.3K. Regarding current trading prices, ACONW is priced at $0.02 on the NASDAQ, while KERNW trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACONW currently has a P/E ratio of N/A, whereas KERNW's P/E ratio is -0.00. In terms of profitability, ACONW's ROE is -0.54%, compared to KERNW's ROE of -0.17%. Regarding short-term risk, ACONW is less volatile compared to KERNW. This indicates lower risk in terms of short-term price fluctuations for ACONW.Check KERNW's competition here
MSP Recovery, Inc. (NASDAQ: LIFWW)
ACONW vs LIFWW Comparison July 2026
Aclarion, Inc. (NASDAQ: ACONW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACONW stands at 11.7K. In comparison, LIFWW has a market cap of 60.1K. Regarding current trading prices, ACONW is priced at $0.02 on the NASDAQ, while LIFWW trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACONW currently has a P/E ratio of N/A, whereas LIFWW's P/E ratio is N/A. In terms of profitability, ACONW's ROE is -0.54%, compared to LIFWW's ROE of +1.56%. Regarding short-term risk, ACONW is similarly volatile compared to LIFWW. This indicates similar risk in terms of short-term price fluctuations for ACONW.Check LIFWW's competition here
Zhongchao Inc. (NASDAQ: ZCMD)
ACONW vs ZCMD Comparison July 2026
Aclarion, Inc. (NASDAQ: ACONW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACONW stands at 11.7K. In comparison, ZCMD has a market cap of 58K. Regarding current trading prices, ACONW is priced at $0.02 on the NASDAQ, while ZCMD trades at $1.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACONW currently has a P/E ratio of N/A, whereas ZCMD's P/E ratio is -0.06. In terms of profitability, ACONW's ROE is -0.54%, compared to ZCMD's ROE of -0.32%. Regarding short-term risk, ACONW is less volatile compared to ZCMD. This indicates lower risk in terms of short-term price fluctuations for ACONW.Check ZCMD's competition here
CareMax, Inc. (NASDAQ: CMAXW)
ACONW vs CMAXW Comparison July 2026
Aclarion, Inc. (NASDAQ: ACONW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACONW stands at 11.7K. In comparison, CMAXW has a market cap of 36.4K. Regarding current trading prices, ACONW is priced at $0.02 on the NASDAQ, while CMAXW trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACONW currently has a P/E ratio of N/A, whereas CMAXW's P/E ratio is N/A. In terms of profitability, ACONW's ROE is -0.54%, compared to CMAXW's ROE of -2.01%. Regarding short-term risk, ACONW is similarly volatile compared to CMAXW. This indicates similar risk in terms of short-term price fluctuations for ACONW.Check CMAXW's competition here
Affymetrix, Inc. (NASDAQ: AFFX)
ACONW vs AFFX Comparison July 2026
Aclarion, Inc. (NASDAQ: ACONW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACONW stands at 11.7K. In comparison, AFFX has a market cap of 0. Regarding current trading prices, ACONW is priced at $0.02 on the NASDAQ, while AFFX trades at $14.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACONW currently has a P/E ratio of N/A, whereas AFFX's P/E ratio is N/A. In terms of profitability, ACONW's ROE is -0.54%, compared to AFFX's ROE of +0.03%. Regarding short-term risk, ACONW is less volatile compared to AFFX. This indicates lower risk in terms of short-term price fluctuations for ACONW.Check AFFX's competition here
CareCloud, Inc. (NASDAQ: MTBCO)
ACONW vs MTBCO Comparison July 2026
Aclarion, Inc. (NASDAQ: ACONW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACONW stands at 11.7K. In comparison, MTBCO has a market cap of 0. Regarding current trading prices, ACONW is priced at $0.02 on the NASDAQ, while MTBCO trades at $25.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACONW currently has a P/E ratio of N/A, whereas MTBCO's P/E ratio is N/A. In terms of profitability, ACONW's ROE is -0.54%, compared to MTBCO's ROE of +0.17%. Regarding short-term risk, ACONW is less volatile compared to MTBCO. This indicates lower risk in terms of short-term price fluctuations for ACONW.Check MTBCO's competition here
MSP Recovery, Inc. (NASDAQ: MSPRV)
ACONW vs MSPRV Comparison July 2026
Aclarion, Inc. (NASDAQ: ACONW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACONW stands at 11.7K. In comparison, MSPRV has a market cap of 0. Regarding current trading prices, ACONW is priced at $0.02 on the NASDAQ, while MSPRV trades at $0.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACONW currently has a P/E ratio of N/A, whereas MSPRV's P/E ratio is N/A. In terms of profitability, ACONW's ROE is -0.54%, compared to MSPRV's ROE of N/A. Regarding short-term risk, ACONW is less volatile compared to MSPRV. This indicates lower risk in terms of short-term price fluctuations for ACONW.Check MSPRV's competition here
Convey Health Solutions Holdings, Inc. (NYSE: CNVY)
ACONW vs CNVY Comparison July 2026
Aclarion, Inc. (NASDAQ: ACONW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACONW stands at 11.7K. In comparison, CNVY has a market cap of 0. Regarding current trading prices, ACONW is priced at $0.02 on the NASDAQ, while CNVY trades at $10.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACONW currently has a P/E ratio of N/A, whereas CNVY's P/E ratio is -71.50. In terms of profitability, ACONW's ROE is -0.54%, compared to CNVY's ROE of -0.02%. Regarding short-term risk, ACONW is less volatile compared to CNVY. This indicates lower risk in terms of short-term price fluctuations for ACONW.Check CNVY's competition here
CareCloud, Inc. (NASDAQ: MTBCP)
ACONW vs MTBCP Comparison July 2026
Aclarion, Inc. (NASDAQ: ACONW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACONW stands at 11.7K. In comparison, MTBCP has a market cap of 0. Regarding current trading prices, ACONW is priced at $0.02 on the NASDAQ, while MTBCP trades at $26.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACONW currently has a P/E ratio of N/A, whereas MTBCP's P/E ratio is N/A. In terms of profitability, ACONW's ROE is -0.54%, compared to MTBCP's ROE of +0.17%. Regarding short-term risk, ACONW is less volatile compared to MTBCP. This indicates lower risk in terms of short-term price fluctuations for ACONW.Check MTBCP's competition here
CareCloud, Inc. (NASDAQ: MTBC)
ACONW vs MTBC Comparison July 2026
Aclarion, Inc. (NASDAQ: ACONW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACONW stands at 11.7K. In comparison, MTBC has a market cap of 0. Regarding current trading prices, ACONW is priced at $0.02 on the NASDAQ, while MTBC trades at $3.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACONW currently has a P/E ratio of N/A, whereas MTBC's P/E ratio is N/A. In terms of profitability, ACONW's ROE is -0.54%, compared to MTBC's ROE of +0.17%. Regarding short-term risk, ACONW is less volatile compared to MTBC. This indicates lower risk in terms of short-term price fluctuations for ACONW.Check MTBC's competition here
IMS Health Holdings, Inc. (NYSE: IMS)
ACONW vs IMS Comparison July 2026
Aclarion, Inc. (NASDAQ: ACONW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACONW stands at 11.7K. In comparison, IMS has a market cap of 0. Regarding current trading prices, ACONW is priced at $0.02 on the NASDAQ, while IMS trades at $31.34.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACONW currently has a P/E ratio of N/A, whereas IMS's P/E ratio is N/A. In terms of profitability, ACONW's ROE is -0.54%, compared to IMS's ROE of +0.27%. Regarding short-term risk, ACONW is less volatile compared to IMS. This indicates lower risk in terms of short-term price fluctuations for ACONW.Check IMS's competition here
Alkuri Global Acquisition Corp. (NASDAQ: KURIU)
ACONW vs KURIU Comparison July 2026
Aclarion, Inc. (NASDAQ: ACONW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACONW stands at 11.7K. In comparison, KURIU has a market cap of 0. Regarding current trading prices, ACONW is priced at $0.02 on the NASDAQ, while KURIU trades at $9.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACONW currently has a P/E ratio of N/A, whereas KURIU's P/E ratio is N/A. In terms of profitability, ACONW's ROE is -0.54%, compared to KURIU's ROE of +1.06%. Regarding short-term risk, ACONW is less volatile compared to KURIU. This indicates lower risk in terms of short-term price fluctuations for ACONW.Check KURIU's competition here
Change Healthcare Inc. (NASDAQ: CHNG)
ACONW vs CHNG Comparison July 2026
Aclarion, Inc. (NASDAQ: ACONW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACONW stands at 11.7K. In comparison, CHNG has a market cap of 0. Regarding current trading prices, ACONW is priced at $0.02 on the NASDAQ, while CHNG trades at $27.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACONW currently has a P/E ratio of N/A, whereas CHNG's P/E ratio is -152.72. In terms of profitability, ACONW's ROE is -0.54%, compared to CHNG's ROE of -0.05%. Regarding short-term risk, ACONW is less volatile compared to CHNG. This indicates lower risk in terms of short-term price fluctuations for ACONW.Check CHNG's competition here
Change Healthcare Inc. (NASDAQ: CHNGU)
ACONW vs CHNGU Comparison July 2026
Aclarion, Inc. (NASDAQ: ACONW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACONW stands at 11.7K. In comparison, CHNGU has a market cap of 0. Regarding current trading prices, ACONW is priced at $0.02 on the NASDAQ, while CHNGU trades at $73.71.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACONW currently has a P/E ratio of N/A, whereas CHNGU's P/E ratio is N/A. In terms of profitability, ACONW's ROE is -0.54%, compared to CHNGU's ROE of -0.05%. Regarding short-term risk, ACONW is less volatile compared to CHNGU. This indicates lower risk in terms of short-term price fluctuations for ACONW.Check CHNGU's competition here
Nava Health MD, LLC (NASDAQ: NAVA)
ACONW vs NAVA Comparison July 2026
Aclarion, Inc. (NASDAQ: ACONW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACONW stands at 11.7K. In comparison, NAVA has a market cap of 0. Regarding current trading prices, ACONW is priced at $0.02 on the NASDAQ, while NAVA trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACONW currently has a P/E ratio of N/A, whereas NAVA's P/E ratio is N/A. In terms of profitability, ACONW's ROE is -0.54%, compared to NAVA's ROE of +0.15%. Regarding short-term risk, ACONW is not fully comparable compared to NAVA. This indicates unavailable risk data in terms of short-term price fluctuations for ACONW.Check NAVA's competition here